24239

0

MEDIORG

img img img img
No Data Available

MEDICAMEN ORGANICS LTD Share Price Update

As of the latest trading session, MEDICAMEN ORGANICS LTD share price is currently at ₹22.95, which is up by ₹1.05 from its previous closing. Today, the stock has fluctuated between ₹22.85 and ₹22.95. Over the past year, MEDICAMEN ORGANICS LTD has achieved a return of -22.47%. In the last month alone, the return has been -24.09%.

MEDICAMEN ORGANICS LTD performance

Today’s low

Today’s high

₹ 22.85 ₹ 22.95
₹ 22.95

52 week low

52 week high

₹ 19.60 ₹ 49.70
₹ 22.95

Open Price

₹ 22.95

Prev. Close

₹ 21.90

Volume (Shares)

10000.00

Total traded value

₹ 2.29

Upper Circuit

₹ 22.95

Lower Circuit

₹ 20.85

info

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

MEDICAMEN ORGANICS LTD fundamentals


  • Market cap (Cr)

    26.90

  • P/E Ratio (TTM)

    7.82

  • Beta

    0.73

  • Book Value / share

    24.76

  • Return on equity

    14.54%

  • EPS (TTM)

    2.80

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    0.00

info icon alternate text
  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text

MEDICAMEN ORGANICS LTD Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Revenue 37.09
Operating Expense 32.79
Net Profit 3.27
Net Profit Margin (%) 8.81
Earnings Per Share (EPS) 2.98
EBITDA 5.64
Effective Tax Rate (%) 25.51
Particulars MAR 2024 (Values in Cr)
Revenue 25.27
Operating Expense 21.90
Net Profit 2.62
Net Profit Margin (%) 10.36
Earnings Per Share (EPS) 3.47
EBITDA 5.81
Effective Tax Rate (%) 40.76
Particulars MAR 2023 (Values in Cr)
Revenue 22.15
Operating Expense 21.59
Net Profit 0.97
Net Profit Margin (%) 4.37
Earnings Per Share (EPS) 1.60
EBITDA 2.68
Effective Tax Rate (%) 28.67
Particulars MAR 2022 (Values in Cr)
Revenue 20.98
Operating Expense 20.93
Net Profit 0.09
Net Profit Margin (%) 0.42
Earnings Per Share (EPS) 0.15
EBITDA 1.41
Effective Tax Rate (%) 61.53
Particulars MAR 2021 (Values in Cr)
Revenue 25.05
Operating Expense 24.57
Net Profit 0.30
Net Profit Margin (%) 1.19
Earnings Per Share (EPS) 0.50
EBITDA 1.65
Effective Tax Rate (%) 38.77
Particulars MAR 2025 (Values in Cr)
Book Value / Share 25.11
ROE % 17.85
ROCE % 16.85
Total Debt to Total Equity 0.55
EBITDA Margin 17.57
Particulars MAR 2024 (Values in Cr)
Book Value / Share 17.74
ROE % 13.11
ROCE % 14.33
Total Debt to Total Equity 0.83
EBITDA Margin 18.84
Particulars MAR 2025 (Values in Cr)
Book Value / Share 24.76
ROE % 14.54
ROCE % 14.04
Total Debt to Total Equity 0.55
EBITDA Margin 15.26
Particulars MAR 2024 (Values in Cr)
Book Value / Share 17.74
ROE % 16.50
ROCE % 16.41
Total Debt to Total Equity 1.01
EBITDA Margin 18.84
Particulars MAR 2023 (Values in Cr)
Book Value / Share 14.97
ROE % 11.73
ROCE % 10.09
Total Debt to Total Equity 1.33
EBITDA Margin 12.10
Particulars MAR 2022 (Values in Cr)
Book Value / Share 12.60
ROE % 1.20
ROCE % 4.08
Total Debt to Total Equity 1.32
EBITDA Margin 6.72
Particulars MAR 2021 (Values in Cr)
Book Value / Share 12.45
ROE % 4.12
ROCE % 5.92
Total Debt to Total Equity 1.23
EBITDA Margin 6.59
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 4.13
Total Assets 59.20
Total Liabilities 59.20
Total Equity 30.48
Share Outstanding 1
Price to Book Ratio 0.88
Return on Assets (%) 6.83
Return on Capital (%) 9.45
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.55
Total Assets 38.44
Total Liabilities 38.44
Total Equity 15.25
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 6.82
Return on Capital (%) 9.4
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 3.26
Total Assets 57.44
Total Liabilities 57.44
Total Equity 29.72
Share Outstanding 1
Price to Book Ratio 0.88
Return on Assets (%) 5.69
Return on Capital (%) 7.81
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.55
Total Assets 38.44
Total Liabilities 38.44
Total Equity 15.25
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 6.82
Return on Capital (%) 9.4
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.52
Total Assets 32.58
Total Liabilities 32.58
Total Equity 8.97
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 2.97
Return on Capital (%) 4.67
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.43
Total Assets 27.07
Total Liabilities 27.07
Total Equity 7.55
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 0.34
Return on Capital (%) 0.52
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.88
Total Assets 26.34
Total Liabilities 26.34
Total Equity 7.46
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 1.13
Return on Capital (%) 1.75
Particulars MAR 2025 (Values in Cr)
Net Income 5.43
Cash from Operations -4.44
Cash from Investing -2.35
Cash from Financing 10.47
Net change in Cash 3.57
Free Cash Flow -2.00
Particulars MAR 2024 (Values in Cr)
Net Income 3.38
Cash from Operations -3.48
Cash from Investing -0.33
Cash from Financing 4.01
Net change in Cash 0.01
Free Cash Flow -3.13
Particulars MAR 2025 (Values in Cr)
Net Income 4.38
Cash from Operations -4.81
Cash from Investing -2.62
Cash from Financing 10.25
Net change in Cash 2.71
Free Cash Flow -2.36
Particulars MAR 2024 (Values in Cr)
Net Income 3.38
Cash from Operations -3.48
Cash from Investing -0.33
Cash from Financing 4.01
Net change in Cash 0.01
Free Cash Flow -3.13
Particulars MAR 2023 (Values in Cr)
Net Income 1.35
Cash from Operations -0.53
Cash from Investing -0.28
Cash from Financing 0.93
Net change in Cash 0.07
Free Cash Flow -0.24
Particulars MAR 2022 (Values in Cr)
Net Income 0.25
Cash from Operations 0.10
Cash from Investing -0.59
Cash from Financing 0.18
Net change in Cash -0.37
Free Cash Flow 0.71
Particulars MAR 2021 (Values in Cr)
Net Income 0.49
Cash from Operations -1.11
Cash from Investing -0.01
Cash from Financing 1.26
Net change in Cash 0.09
Free Cash Flow -1.09
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 24.99 10.82 1.29 191.51 23.12 / 42.00
BLISS GVS PHARMA LTD. 216.15 20.66 2.01 2286.63 105.05 / 244.05
CIPLA LTD 1329.90 22.59 3.26 107426.75 1283.00 / 1672.20
FERMENTA BIOTECH LIMITED 336.60 11.20 2.53 990.65 240.00 / 399.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 24.99 24.03 3.48 191.51 23.12 / 42.00
AMRUTAJAN HEALTH LTD 556.05 27.80 4.69 1607.58 540.05 / 789.95
ASTRAZENECA PHARMA INDIA LTD. 8768.50 105.38 27.43 21921.25 6501.60 / 10653.05
BLISS GVS PHARMA LTD. 216.15 29.45 2.07 2286.63 105.05 / 244.05

MEDICAMEN ORGANICS LTD shareholding pattern

Holding

35.11%
61.26%
0.06%
3.55%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

MEDICAMEN ORGANICS LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
22.95 4.79 redarrow
red-green-graph indicator
11 Bearish
5 Bullish
  • 5 Days 21.90
  • 26 Days 23.90
  • 10 Days 22.60
  • 50 Days 25.00
  • 12 Days 22.90
  • 100 Days 27.60
  • 20 Days 23.60
  • 200 Days 33.90
21.55 PIVOT

First Support

21.20

First Resistance

22.25

Second Support

20.50

Second Resistance

22.60

Third Support

20.15

Third Resistance

23.30

RSI

40.80

ADX

17.90

MACD

-1.03

Williams % R

-80.83

Commodity Channel Index (CCI)

-105.18

Date

2026-03-11

Week

22333.00

Same Day

10000.00

Month

20333.00

1 Year

0.74

3 Year

0.56

Over 1 Month

-24.09%

down

Over 1 Year

-22.47%

down

Over 3 Months

-15.76%

down

Over 3 Years

0.00%

down

Over 6 Months

-37.42%

down

Over 5 Years

0.00%

down

MEDICAMEN ORGANICS LTD Corporate Actions

Top Gainers

MEDICAMEN ORGANICS LTD Share Price

Medicamen Organics Limited was formerly incorporated on March 15, 1995 as Panchdeep Pharmaceuticals Limited', as Public Limited Company dated March 15, 1995 issued by the Registrar of Companies, Delhi and Haryana. Subsequently, the name of Company changed to Medicamen Organics Limited' and a fresh Certificate of Incorporation on November 14, 1995 was issued by the Registrar of Companies, Delhi and Haryana at Delhi.

Medicamen Organics are engaged in developing, manufacturing and distribution of broad range of pharmaceutical dosage including generic dosage in form of Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry Powders for Government (including both State and Central Governments) and Private Institutions as contract manufacturer / third party manufacturer. The Company market product to private pharma companies in domestic as well as international markets through third party distributors or on loan license basis.

Further, Company is strategically focusing on establishing a direct presence in international market for an instance in 2023, it directly exported the product in Burundi. These products are marketed across India as well as African, Commonwealth of Independent States (CIS) region and South East Asian Countries like Congo, Benin, Cameg, Togo, Senegal, Burkina Faso, Philippines, Myanmar, Mozambique, Togo, Burundi, Kyrgyzstan and Kenya by third-party distributor.

In 1996, the Company started with trading of pharmaceuticals for supplies to various Government departments. During the period 2007, it started construction for own pharma unit at Ranipur, in Haridwar and received WHO/GMP Certificate for Unit I. In 2010, it got license for manufacturing of food supplements, like protein powders, vitamin tablets and syrups etc.

In 2017, it formed a joint venture with Denish Company and gave them authority for worldwide export of Iron Products. The joint venture company, in turn, got 50% equity in the Company. Further, the Company reconstructed Unit-II for production of tablets, capsules, oral liquids, ointments and dry power, veterinary medicines, etc. and got first license for pharma in this unit.


The Company is proposing the Initial Public Offer of 32,00,000 Fresh Issue Equity Shares.

Parent organization Indian Private
NSE symbol MEDIORG
Founded 1995
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Medicamen Organics Ltd?

Answer Field

Medicamen Organics Ltd share price is for NSE ₹ 22.95 & for BSE ₹ 0.00 as on Mar 12 2026 01:17 PM.

What is the Market Cap of Medicamen Organics Ltd Share?

Answer Field

The market cap of Medicamen Organics Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Mar 12 2026 01:17 PM.

What is the 52 Week High and Low of Medicamen Organics Ltd?

Answer Field

The 52 Week High and Low of Medicamen Organics Ltd for NSE is ₹ 49.70 and ₹ 19.60 and for BSE is ₹ 0.00 and ₹ 0.00.

What is 1 year return for Medicamen Organics Ltd?

Answer Field

The 1 year returns on the stock has been -22.47%.

What is the P/E Ratio of Medicamen Organics Ltd Share?

Answer Field

As on Mar 12 2026 01:17 PM the price-to-earnings (PE) ratio for Medicamen Organics Ltd share is 7.82.

What is the PB ratio of Medicamen Organics Ltd Share?

Answer Field

As on Mar 12 2026 01:17 PM, the price-to-book (PB) ratio for Medicamen Organics Ltd share is 24.76.

How to Buy Medicamen Organics Ltd Share?

Answer Field

You can trade in Medicamen Organics Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Medicamen Organics Ltd Share on Bajaj Broking App?

Answer Field

To buy Medicamen Organics Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Medicamen Organics Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59